在EB66®细胞系中生长特性改善的乙型流感病毒反向遗传骨架作为疫苗种子病毒制备基础
研究收集并测序71株乙型流感病毒,在EB66®细胞系中评估其进入、复制及多周期传代产量,发现株间产量差异大;选取B/Victoria和B/Yamagata谱系高生长株制备反向遗传骨架,替换低生长株HA和NA后骨架仍保持良好生长,且既往报道增强细胞培养流感病毒生长的化合物亦可提高EB66®细胞系病毒产量。
要点
- 71株乙型流感病毒在EB66®细胞单周期试验中均可感染细胞。
- 多周期试验中不同毒株病毒子代产量差异大。
- 高生长株反向遗传骨架替换低生长株HA和NA后仍保持良好生长。
核心结论
- 所选乙型流感病毒反向遗传骨架在EB66®细胞系中保持良好生长特性,为疫苗种子病毒制备的可行选择。
- 既往报道增强细胞培养流感病毒生长的化合物亦可提高EB66®细胞系病毒产量。
研究设计与样本
- 收集、整理并测序71株乙型流感病毒,选株兼顾分离日期和谱系多样性。
- 在EB66®细胞系中进行单周期进入与复制试验及多周期病毒子代产量试验。
- 选取B/Victoria和B/Yamagata谱系高生长株,用反向遗传系统制备疫苗骨架。
主要发现
- 71株病毒在EB66®细胞单周期试验中均可感染该细胞。
- 多周期试验中病毒子代产量株间差异大。
- 将低生长株HA和NA替换至所选骨架后,骨架在EB66®细胞中维持良好生长。
- 既往报道增强细胞培养流感病毒生长的化合物在EB66®细胞系中亦提高病毒产量。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Vaccination remains the best available prophylaxis to prevent influenza virus infections, yet current inadequacies in influenza virus vaccine manufacturing often lead to vaccine shortages at times when the vaccine is most needed, as it was the case during the last influenza virus pandemic. Novel influenza virus vaccine production systems will be crucial to improve public health and safety. Here we report the optimization of influenza B virus growth in the proprietary EB66® cell line, currently in use for human vaccine production. To this end, we collected, curated and sequenced 71 influenza B viruses selected for high diversity in date of isolation and lineage. This viral collection was tested for ability to enter and replicate within EB66® cells in a single cycle assay and appears to readily infect these cells. When the collection was tested for viral progeny production in a multi-cycle assay, we found a large variation from strain to strain. The strains with the top growth characteristics from the B/Victoria and B/Yamagata lineages were selected for vaccine backbone generation using a reverse genetics system. We then showed that these backbones maintain their desirable growth within EB66® cells when the HA and NA from poorly growing strains were substituted for the parental segments, indicating that the selected backbones are viable options for vaccine production in EB66®. Finally, we show that compounds previously reported to enhance influenza virus growth in cell culture also increase virus production in the EB66® cell line.
引用
- White KM, Ayllon J, Mena I, et al. Influenza B virus reverse genetic backbones with improved growth properties in the EB66® cell line as basis for vaccine seed virus generation. Vaccine. 2018. PMID: 29395518. doi:10.1016/j.vaccine.2018.01.050
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。